SMTL ID : 4riy.2 (1 other biounit)

Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-E909G mutation

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.98 Å

Oligo State

hetero-1-1-mer

Ligands

1 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)

ANP.1: 19 residues within 4Å: Chain A: L.21, G.22, S.23, G.24, V.25, V.29, C.46, K.48, T.93, Q.94, Y.95, L.96, N.140, R.144, N.145, L.147, D.158, Y.174 Ligands: MG.2 11 PLIP interactions: 11 interactions with chain A Hydrogen bonds: A:V.25, A:K.48, A:T.93, A:Q.94, A:L.96, A:N.140, A:N.140, A:R.144, A:R.144, A:N.145 Salt bridges: A:K.48

2 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 4 residues within 4Å: Chain A: K.48, N.145, D.158 Ligands: ANP.1 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:D.158 MG.4: 2 residues within 4Å: Chain B: N.165 Ligands: ADP.3 No protein-ligand interaction detected (PLIP)

1 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)

ADP.3: 16 residues within 4Å: Chain B: L.41, F.46, V.49, A.66, K.68, T.113, Q.114, L.115, M.116, G.119, C.120, R.164, N.165, L.167, D.178 Ligands: MG.4 6 PLIP interactions: 6 interactions with chain B Hydrogen bonds: B:T.113, B:M.116, B:R.164, B:D.178 Salt bridges: B:K.68, B:K.68

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Littlefield, P. et al., Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations. Sci.Signal. (2014)

Release Date

2014-12-10

Peptides

Receptor tyrosine-protein kinase erbB-3: A
Epidermal growth factor receptor: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

Receptor tyrosine-protein kinase erbB-3

Epidermal growth factor receptor

Related Entries With Identical Sequence